Multidiscliplinary teams (MDTs) are increasingly used to aid decision-making in the care of patients with cancer, but their clinical value can be difficult to quantify. A prospective study has now assessed the use of MDTs for patients with urological cancers. Future refinement of MDT organization is required to optimize effectiveness.
This is a preview of subscription content, log in via an institution to check access.
References
Taylor, C. et al. Multidisciplinary team working in cancer: What is the evidence? BMJ 340, c951 (2010).
Rao, K. et al. Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre—impact on clinical decision-making and implications for patient inclusion. BJU Int. http://dx.doi.org/10.1111/bju.12764.
Lamb, B. W. et al. Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann. Surg. Oncol. 18, 2116–2125 (2011).
Lamb, B. W., Sevdalis, N., Benn, J., Vincent, C. & Green, J. S. A. Multidisciplinary cancer team meeting structure and treatment decisions: a prospective correlational study. Ann. Surg. Oncol. 20, 715–722 (2013).
Lamb, B. W., Green, J. S. A., Vincent, C. & Sevdalis, N. Decision making in surgical oncology. Surg. Oncol. 20, 163–168 (2011).
Fennell, M. L., Das, I. P., Clauser, S., Petrelli, N. & Salner, A. The organization of multidisciplinary care teams: modeling internal and external influences on cancer care quality. J. Natl Cancer Inst. Monogr. 40, 72–80 (2010).
Lamb, B. W. et al. Facilitators and barriers to teamworking and patient centeredness in multidisciplinary cancer teams: findings of a national study. Ann. Surg. Oncol. 20, 1408–1416 (2013).
Wright, F. C., De Vito, C., Langer, B. & Hunter, A. Multidisciplinary cancer conferences: a systematic review and development of practice standards. Eur. J. Cancer 43, 1002–1010 (2007).
Keating, N. L. et al. Tumor boards and the quality of cancer care. J. Natl Cancer Inst. 105, 113–121 (2013).
Jalil, R. et al. Validation of team performance assessment of multidisciplinary tumor boards. J. Urol. 192, 891–898 (2014).
Acknowledgements
This article was prepared on behalf of the Imperial Cancer MDT research group, which consists of (in alphabetical order): Sonal Arora, James S. A. Green, Rozh Jalil, Benjamin Lamb, Manmeet Matharoo, Somita Sarkar, Nick Sevdalis, Sujay Shah and Tajana A. Soukup. N.S. is affiliated with the Imperial Patient Safety Translational Research Centre (www.cpssq.org), which is funded by the UK National Institute for Health Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
N.S. has been a paid advisor to Green Cross Medical Ltd, and delivers teaching and consultancy-based work on evaluating and improving MDT effectiveness and team processes for hospitals in the UK and internationally. J.S.A.G. has received funding from the National Cancer Action Team for the development of a team training/feedback system for cancer MDTs through Green Cross Medical Ltd.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Sevdalis, N., Green, J. Expanding the evidence for multidisciplinary team cancer care. Nat Rev Urol 11, 668–669 (2014). https://doi.org/10.1038/nrurol.2014.280
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2014.280
- Springer Nature Limited
This article is cited by
-
The impact of multidisciplinary team conferences in urologic cancer in a tertiary hospital
International Urology and Nephrology (2021)